US 7572834
Rasagiline formulations and processes for their preparation
granted A61KA61K31/135A61K9/2018
Quick answer
US patent 7572834 (Rasagiline formulations and processes for their preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/135, A61K9/2018, A61K9/2059